[Prevention of neural tube defects. An important health and social problem]

J Czochańska1, M Lech

  • 1Klinika Neurologii Dzieci i Młodziezy oraz, Instytut Matki i Dziecka w Warszawie.

Przeglad Lekarski
|July 10, 1998
PubMed

Insights

Neural tube defects (NTDs) cause severe childhood disability and mortality. Folic acid supplementation in women of reproductive age significantly reduces NTD incidence, highlighting the importance of primary prevention programs.

Area of Science:

  • Neurology
  • Public Health
  • Genetics

Context:

  • Neural tube defects (NTDs) are common congenital malformations impacting children's health.
  • Poland faces a high and stable incidence of NTDs, with 800-1150 cases annually.
  • Encephalocele accounts for approximately 50% of these NTD cases.

Purpose:

  • To present the Programme of Primary Prevention of NTDs in Poland.
  • To emphasize the role of prophylactic measures in mitigating NTD-related morbidity and mortality.
  • To highlight the incorporation of this program into the National Health Programme (1996-2005).

Summary:

  • NTDs are a significant cause of childhood disability and mortality.
  • Primary prevention through folic acid supplementation has proven effective, reducing NTD rates by 70%.
  • The presented program integrates this evidence-based strategy into national health initiatives.

Impact:

  • Reduced incidence of neural tube defects in newborns.
  • Improved child health outcomes and decreased mortality rates.
  • Strengthened public health strategies for congenital malformation prevention.

Related Concept Videos

Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the anterior...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...